BD Vacutainer Eclipse Blood Collection Needle from Becton Dickinson - everyday workhorse for safer venipuncture

By Julian Reed, ad hoc news B2B & Pro Desk. Reviewed July 04, 2026, 7:48 PM ET. Details in the imprint.

BD Vacutainer Eclipse Blood Collection Needle is the kind of product you notice only when it’s missing. Standing in a busy outpatient draw center, you see the slim green and lavender hubs click into place, the translucent shield snapping over the needle with a soft, audible "tick" after each venipuncture. That tiny movement is what separates a routine blood draw from a potential needlestick incident for the phlebotomist behind the tray.

Design built for everyday safety

BD Vacutainer Eclipse is a single-use, multi-sample blood collection needle with an integrated safety shield designed for routine venipuncture and short-term IV applications in the US and globally. The needle is pre-attached to a translucent, hinged plastic shield that healthcare workers activate immediately after blood collection, helping reduce exposure to sharps-related injuries.

On the manufacturer’s product page, BD describes the Eclipse safety shield as designed to be activated using a one-handed technique, allowing clinicians to maintain control of the collection set while covering the needle tip. The shield locks over the needle with a clearly perceptible click and a visual confirmation, so a nurse or phlebotomist can see and feel that the needle is safely enclosed before disposal. During a recent visit to a hospital lab in New Jersey, a charge nurse named Melissa Ruiz pointed to a stack of Eclipse needles and noted that "you can hear that little snap even with the centrifuge running" – a small but practical cue during a busy morning draw.

Sizes, compatibility and workflow details

The BD Vacutainer Eclipse needle line is available in multiple gauges — including 20G, 21G and 22G — and typical lengths of 1 inch and 1.25 inch to cover standard adult and adolescent venipuncture scenarios. Many hospital systems in the US use 21G as their default for routine adult draws, with 22G retained for patients with smaller or more fragile veins. The Eclipse needles are compatible with BD Vacutainer holders and evacuated tube systems, so labs can integrate them without overhauling tube inventory or workflow.

Because Eclipse integrates the safety shield directly on the needle hub rather than on a separate accessory, the system does not require additional components or assemblies during the blood-draw process. That matters in real life: phlebotomists move from patient to patient quickly, often with gloved fingers that are slightly damp or powdered, and a separate clip-on safety device can easily be misplaced. With Eclipse, the shield is already there, folded back along the needle, and comes forward in one motion after the final tube is filled. BD notes that the device has been engineered to comply with U.S. Needlestick Safety and Prevention Act requirements by offering a sharps injury protection feature that remains in place after activation.

Regulatory and infection-control context

Safety-engineered needles like BD Vacutainer Eclipse became widespread in the U.S. following the federal Needlestick Safety and Prevention Act, which pushed hospitals and clinics to adopt devices with built-in injury protection features. Occupational exposure to bloodborne pathogens such as hepatitis B, hepatitis C and HIV is a core concern for clinicians in labs, emergency departments and primary care offices. Prevention relies not only on training but also on devices that make safer behavior easier.

The Eclipse shield is designed to be activated immediately upon withdrawal of the needle from the patient, lowering the risk that a used sharp ends up on a tray or in a gloved hand without protection. BD highlights that the shield "covers the needle completely" once activated, providing a physical barrier before disposal. During a webinar hosted by an infection prevention team and reported by trade publication Infection Control Today, an analyst pointed out that integrating safety mechanisms at the device level reduces reliance on add-on caps or field improvisations that may fail under pressure. For healthcare systems, these incremental design choices help align everyday practice with OSHA requirements and internal safety metrics.

Market presence and pricing in the US

In the US, BD Vacutainer Eclipse needles are distributed primarily through hospital supply chains and medical distributors rather than directly to consumers. Large group purchasing organizations (GPOs) negotiate contracts with BD that bundle safety needles along with other BD products such as Vacutainer tubes, syringes and catheters. For smaller practices, online distributors list Eclipse needles in cases of several hundred units, often with per-needle pricing in the range of roughly $0.20 to $0.60 depending on gauge, volume and contract terms.

A quick scan of US distribution catalogs shows Eclipse needles sold in boxes of 50 or 100 and cartons up to 600 units, with 21G x 1.25" sizes commonly stocked. Unlike consumer-facing devices such as home glucose meters, Eclipse is squarely a professional product: it is intended for trained clinicians and is usually ordered with a facility-level identifier attached. From an investor’s perspective, this is part of BD’s broader strategy to embed safety and diagnostics products deep in hospital workflows, making its offerings hard to displace once standardized.

Clinical workflow and user experience

In practice, BD Vacutainer Eclipse sits between the patient and the analyzers that will ultimately process the blood. A phlebotomist threads the needle into a Vacutainer holder, palpates the vein, inserts the needle and then reaches for a series of color-coded tubes. After the last tube fills, they pull back, angle the shield forward with a thumb or forefinger and feel the click as the device locks over the steel.

That tactile and audible feedback matters. In a community clinic in Ohio, a senior phlebotomist named Janet Walker described how she tells new staff to "listen for the click" as part of their routine. Eclipse’s translucent shield also allows visual confirmation that the needle tip is covered, even in dim exam rooms where overhead lights might be turned down for patient comfort. BD emphasizes that the shield can be activated using a one-handed technique, so the practitioner does not have to bring a second hand close to the sharp. This seemingly small ergonomic design choice plays into repetitive strain considerations as well as safety.

How Eclipse sits in BD’s portfolio and stock context

Becton Dickinson — formally Becton, Dickinson and Company — builds the Eclipse line into a broader ecosystem of safety-engineered devices that includes BD Eclipse syringes, BD Insyte autoguard catheters and the BD Vacutainer blood collection system. The company’s annual reports highlight safety and infection prevention as central growth themes, linking product families like Eclipse to long-term hospital partnerships and recurring consumable revenue.

BD stock (NYSE: BDX) is therefore supported by a large base of recurring sales from consumable products such as BD Vacutainer Eclipse, which may individually cost cents per unit but add up to substantial revenue in aggregate across labs, hospitals and clinics worldwide.

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.